NRC Health NRC
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.44M | 5.86M | 9.04M | 11.60M | 16.36M |
| Total Depreciation and Amortization | 8.50M | 8.63M | 8.25M | 7.62M | 7.00M |
| Total Amortization of Deferred Charges | 108.00K | 109.00K | 114.00K | 102.00K | 74.00K |
| Total Other Non-Cash Items | 13.22M | 14.40M | 5.52M | 6.21M | 1.39M |
| Change in Net Operating Assets | -4.51M | 509.00K | 4.07M | 916.00K | 829.00K |
| Cash from Operations | 23.77M | 29.51M | 26.98M | 26.45M | 25.65M |
| Capital Expenditure | -5.32M | -7.87M | -9.55M | -10.71M | -14.03M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -5.32M | -7.87M | -9.55M | -10.71M | -14.03M |
| Total Debt Issued | 55.00M | 31.00M | 51.44M | 84.68M | 106.18M |
| Total Debt Repaid | -32.26M | -22.05M | -38.74M | -68.44M | -79.85M |
| Issuance of Common Stock | 139.00K | 139.00K | 139.00K | 132.00K | 132.00K |
| Repurchase of Common Stock | -25.97M | -19.26M | -17.60M | -20.59M | -27.58M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -13.47M | -12.71M | -11.83M | -10.98M | -11.10M |
| Other Financing Activities | -483.00K | -719.00K | -792.00K | -650.00K | -656.00K |
| Cash from Financing | -17.04M | -23.59M | -17.39M | -15.84M | -12.86M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.41M | -1.95M | 45.00K | -94.00K | -1.24M |